Introduction {#S1}
============

More than a decade ago, in a seminal sibling study to refine understanding of the heritability of autism, Spiker, Risch, and colleagues ([@R1]) explored the foundational question of whether the characterizing traits and features of autism spectrum disorder (ASD) bred true in autism-affected families. Their report documented the startling (and at the time perhaps under-appreciated) observation that what clustered in individual families affected by multiplex autism was [*not*]{.ul} specific profiles or patterns of the three characterizing symptoms of the disorder (social deficits, language/communication deficits, and repetitive/stereotypic motor behavior), rather impairment along a *single* continuous severity dimension, the heritability of which roughly equated to the broad heritability of autism in the population. Stated another way, the severity of the syndrome as a whole bred truer than that of its ostensible component parts. This finding recapitulated the conclusions of other reports that subclinical characteristics of the *entire* autistic syndrome (i.e. sub clinical elevations in all three DSM-IV criterion domains)---the so-called broader-autism phenotype ([@R2],[@R3])- were more commonly manifest in the unaffected relatives of individuals with categorically-diagnosed autistic syndromes than in the general population. These two principal findings motivated a body of research which I reviewed in a previous article in this journal, entitled, *The Quantitative Nature of Autistic Social Impairment* ([@R4]).

How could it be that the total severity of the syndrome itself bred truer than its own symptoms? Or that sub clinical versions of the entirety of the autistic syndrome were traceable in unaffected family members? Numerous explorations of the associations between genotype and phenotype in the autism spectrum disorders (ASD) have now converged upon the same fundamental principle of a single continuous severity dimension, the nature of which, until recently, has been enigmatic. In this article, I will describe how the "downward extension" of quantitative characterization of human behavior from *childhood* (i.e. [after]{.ul} the time when autistic symptomatology usually first manifests) to *infancy* (i.e. before autism develops) is beginning to provide new clues to understanding the manner in which genetic variation relates to the neuropsychiatric impairments that define the condition. This review will cover recent advances which have suggested that ASD may arise from specific combinations of early inherited neurobehavioral susceptibilities---some specific to ASD, some not---and that generally do *not* bear direct 1:1 associations with specific ASD symptoms. A key implication for future pediatric research is that linking genetic variants to these earlier underlying traits rather than to the subsequent symptoms of ASD (once it develops) may be more productive in relating genes to brain to behavior and in devising effective approaches to preventive intervention ([@R5],[@R6]).

Behavioral manifestations of polygenic risk for autism {#S2}
======================================================

It is first important to contextualize the scientific relevance of elucidating tractable early developmental phenotypes, in light of contemporary understanding of the causal structure of autism, a principal aspect of which is that the heritability of the condition is pronounced, on the order of 85% ([@R7]). The past decade has seen remarkable advances in identifying *de novo* (germline) mutations that each represent [rare]{.ul} monogenic causes of ASD ([@R8],[@R9]), though, by definition, account for none of the syndrome's substantial heritability. The number of genes implicated by such studies is over one hundred and growing by the month; each rare syndrome engendered by a deleterious mutation in a given gene presents critical scientific opportunity to explore: a) how hemizygous loss- or gain-of function of that gene can engender a phenocopy of ASD with or without co-occurring neurologic impairments such as epilepsy or intellectual disability; b) how convergent pathogenic mechanisms triggered by mutations in disparate genes might be shared and therefore represent common therapeutic targets; and c) how less disruptive variations in the same genes might contribute incremental causal influence on autistic syndromes.

Despite the demonstrated role of de novo variants, however, it is *polygenic* liability that accounts for the *majority* of the population-attributable risk for ASD ([@R10],[@R11]), including that majority of cases in which ASD is *not* accompanied by intellectual disability. If common allelic variations are cumulatively responsible for a) most cases of autism, and b) the range of sub clinical autistic traits that encompass the general population distribution---these aggregate among the unaffected relatives of ASD probands and are minimally correlated with variation in intellectual functioning---inherited developmental phenotypes may represent far more parsimonious targets for understanding biology than can currently be identified using molecular genetic methods alone.

Notably, deleterious de novo mutations can *combine* with polygenic risk within an individual to give rise to an autistic syndrome ([@R12],[@R13]). Tracing the respective effects of each type of genetic influence to a given behavioral phenotype---especially when they co-occur---has yielded remarkable new insights into understanding the manner in which polygenic risk influences brain and behavior. For example, Moreno DeLuca et al ([@R14]) showed that de novo 16p11.2 deletions incurred a predictable deleterious "shift" in the severity of autistic impairment in offspring (on the order of one to two standard deviations) in relation to what would be [expected]{.ul} on the basis of the average quantitative trait burden (for each respective trait) of his/her parents. Thus, children with de novo deletions of 16p11.2 whose [parents]{.ul} fell in the below-average range for social communication---*yet still entirely within normal limits for adults*---were significantly more likely to be affected by clinical-level ASD than those whose parents' social communication was above average. Recognition that some mutations induce a predictable shift against a measurable genetic background rather than exerting an absolute effect represents an important advance in understanding clinical genomic variation ("Shift Happens" ([@R15])).. A corollary is that background variation within the range of normality can exert a range of quantitative effects on the phenotypic expression of a superimposed "deleterious" mutation.

Population-wide, the inherited behavioral endophenotype indexed by sub clinical variation in the characterizing traits and features of ASD among parents (as measured, for example, using the *Social Responsiveness Scale*) is now known to account for approximately 10 per cent of autistic trait variation among their offspring ([@R16]) and to proportionately elevate risk for a clinical autistic syndrome ([@R17],[@R18]). A question arises, then, to what extent the remaining inherited risk might be captured by measurements of one or more pre-diagnostic behavioral phenotypes representing causal liability *prior* to the onset of a diagnosable autistic syndrome.

Insights from a first generation of prospective studies of later-born infant siblings {#S3}
=====================================================================================

A proliferation of studies of the early development of ASD among high-risk infant siblings of children with ASD has been particularly informative in this regard ([@R19], [@R20], [@R21], [@R22], [@R23], [@R24]) and reviewed by Szatmari et al ([@R25]). The conclusions of these studies have converged upon several important themes. First, the characterizing traits and features of ASD are usually *absent* prior to the age of 12 months---even when ascertaining very subtle versions of those traits among children who go on to develop severe autistic syndromes ([@R26]). Second, *joint* indices of a) sensorimotor dysfunction; b) nuanced components of early precursors of social communication (including social motivation, joint attention, infant vocalization, and response to name); and c) global cognitive development may more robustly predict the development of ASD than any single index ([@R24],[@R26]), but this is only beginning to be understood and will require a next generation of prospective recurrence studies with adequate sample sizes and much more complete phenotypic characterization. Third, when considering predictors for which epidemiologic prevalence in the general population is known (this is not common and a nagging scientific gap), the positive predictive value of each of these factors (or their combinations) for ASD is often more robust in the context of recurrence (i.e. the study of infant siblings of children affected by ASD) than in the general population ([@R27]). This suggests the possibility that some of the measurable early behavioral predictors of ASD may a) arise independently from familial ASD risk and b) subsequently interact with ASD-specific familial risk to amplify liability to the clinical syndrome. Examples of early developmental phenotypes that have been studied in an epidemiologic context and exhibit this pattern---i.e. that may constitute more robust predictors of within-family recurrence of autism than general population risk---include variation in i) *visual social engagement*, ii) *motor coordination*, and iii) *attention problems*, each of which are described in greater detail below. A counter-example is accelerated head growth, which is highly familial but weakly associated with ASD in the general population, and a poor predictor of recurrence in ASD-affected families ([@R28]).

Since many of the "first generation" high-risk infant sibling studies were designed exclusively to focus on "autism-specific" symptoms, the relative difficulty in identifying first year of life behavioral predictors homologous to the characterizing features of the diagnosis has appropriately motivated efforts to progressively *widen* the search space for early predictors of the condition, to phenotypes that are common among children with autism but not necessarily specific to ASD. The first major clues in this regard have come from observations of delayed sensorimotor development ([@R23],[@R24]) and/or the dissociation of typical correlations between motor and language development ([@R29]) among high-risk infants who ultimately develop ASD. This complements a growing body of studies of school-aged children that have repeatedly documented motor coordination impairments occurring among children with ASD ([@R30],[@R31],[@R32],[@R33]), at a frequency that rivals that of language delay in ASD, though still not yet represented in the DSM5 diagnostic criteria for the disorder, and traditionally excluded because of its "nonspecificity" for autism---this is a point to which we will return below. A major obstacle to research in establishing the role of these impairments in the developmental ontogeny of autism is that the methods for measuring meaningful variation in the first year of life are not yet as precise or reliable as those that apply later in development.

Specification of autism endophenotypes appreciable in infancy and early childhood {#S4}
=================================================================================

It is important to emphasize that the road to confirmation, that an early behavioral liability reflects an independent causal influence on autism, is long. First, since autism is largely heritable, a behavioral liability must be shown to be substantially heritable in a genetic epidemiologic context. Second, it must be shown that it aggregates among family members of clinically-affected individuals. Third, it must be shown to be at least partially independent from (minimally-correlated with) other behavioral liabilities that are already established as causal influences on ASD ([@R34]). Fourth, it must predict ASD, either in the general population ([@R35]), or its recurrence in families affected by autism. These are the characteristics of endophenotypes. Notably, phenotypes which predict autism within a family recurrence context (i.e. later-born infant sibling studies) but do NOT predict autism as strongly in an epidemiologic context (i.e. general population studies) constitute behavioral liabilities that are *not necessarily specific to autism*. They may be common in the general population but require interactions with (or joint effects of) other influential factors to engender autism, in the absence of which their predictive influence is more modest.

For most candidate endophenotypes---whether *behavioral*, psychophysiologic ([@R36]), electrophysiologic ([@R37],[@R38]), serologic ([@R39]) or brain-imaging-based ([@R40],[@R41],[@R42],[@R43]; these are outside of the scope of this review and their relation to most *behavioral* endophenotypes currently unknown)---what we know is generally limited to observed associations with autism in casecontrol or recurrence studies, and it is therefore difficult to know the extent to which an observed association reflects *causation* of the condition (as opposed to a correlate or secondary consequence). Since a great deal hinges upon whether or not a candidate endophenotype reflects a causal influence, it should be made a scientific priority for candidate endophenotypes to be subjected to the systematic complement of studies---epidemiologic, family recurrence, prospective prediction, and association with other early predictors---that would "convert" a correlate or co-occuring trait to the status of *endophenotype* and to clarify its relative contribution to population-attributable risk for the condition. If the number of early-appreciable ASD endophenotypes that encompass the totality of polygenic liability to autism is relatively low, precise characterization of early neurobehavioral profiles that predict autism may be well within reach, if such systematic studies are pursued.

The notion of autism as an acquired "redirection" of development in the setting of a critical aggregation of early behavioral liabilities would be consistent with the heritability of *autism* (once it develops) as lying along a *single* continuous severity dimension ([@R1]), and carries with it the profound implication that the condition may not be "fixed" or inevitable, rather prevented before it arises (but perhaps not later) if there are ways to resolve the earlier deficits ([@R6]), a consideration supported by other studies described below.

Non-ASD-specific contributions to the cause of autism {#S5}
=====================================================

In recent analyses of the role of non-ASD-specific neurodevelopmental traits on ASD occurrence or recurrence in families, it was observed that Attention Deficit Hyperactivity Disorder (ADHD) symptoms and motor coordination impairment jointly account for a very significant share of the variance (over 50%) in a) categorical ASD recurrence; b) quantitative trait severity ([@R33]); and c) that siblings of children with ADHD have a four-fold increase in the incidence of autism ([@R45]). These findings are in keeping with earlier observations from general population studies ([@R46]) of substantial genetic overlap between autistic traits and symptoms of either inattention/hyperactivity and developmental coordination disorder. Impairments in attention and motor coordination are strongly genetically-influenced but not specific to autism, and may relate to autism by amplifying the effect of "ASD-specific" factors early in development. Although such traits are sometimes referred to as "co-morbidities," these and other research observations ([@R47], [@R48]) suggest that they may be actual causes of the autistic syndrome. Rather than being discarded (or mathematically regressed away in research studies ([@R49])) it may be as important to include measurement of these traits as it is to measure traits that have traditionally been viewed as more "specific" to autism. A schematic depiction of the genetic epidemiologic relationship between ADHD and autism supported by these data is provided in [Figure 1](#F1){ref-type="fig"}.

In general, behavioral comorbidity is the rule rather than the exception in autism spectrum disorder (ASD). An ASD "comorbidity" can have several fundamentally-distinct causal origins: i) it can arise from chance co-occurrence of ASD with a causally-independent liability (e.g. ASD and diabetes); ii) it can arise as a secondary symptom of ASD (e.g. ASD and aggression); or iii) it can be the late manifestation of a *cause* of ASD. Recently, Hawks et al. ([@R50]) traced the respective origins of autistic and general psychopathologic traits to infancy in an epidemiologic study of 314 twins. Standardized ratings of variation in autistic traits and other non-ASD-related behavioral traits, which are substantially correlated throughout childhood (after the time when autism develops), were found to be *independent* from one another and traceable to distinct genetic structures. The authors concluded that the commonly-observed co-occurence of specific psychiatric syndromes with autism may arise from interactions between autistic symptoms (after they arise) and genetically-independent neuropsychiatric liabilities, suggesting opportunities for preventive amelioration of outcomes of these interactions over the course of development.

It is well known that rare, highly-deleterious genetic variants associated with autism are also associated with intellectual disability, ADHD, epilepsy or schizophrenia across different families. A reconceptualization of autism in which some of its contributing components are specific to autism but others are non-specific provides a direct way of accounting for *pleiotropy* in studies of genotype-phenotype association in developmental disabilities research. Lahey and colleagues ([@R51]) have invoked the concept of "behavioral pleiotropy" on the basis of discovery of highly-heritable symptom clusters accounting for a major share of the attributable causal variance across a wide diversity of neuropsychiatric syndromes, including mood and anxiety disorders, disruptive behavior disorders, and substance use disorders ([@R51]). One of the core symptom domains derived from factor analysis of psychiatric interview data, is *capacity for emotion regulation*. Other lines of investigation have identified additional independent behavioral "building blocks" of psychopathology ([@R52]) that can be tested for alignment with domains of mental functioning that comprise the NIH matrix known as RDoC (Research Domain Criteria) which attempts to parse psychopathology into its developmental causal structure, rather than on manifestations of symptoms after a syndrome of impairment or decompensation emerges.

In the future, interventions targeted to early developmental liabilities that may contribute risk for ASD (whether specific or not specific to ASD) can be directly tested for their ability to reduce long-term disability in ASD, particularly among infants known to be at elevated risk. Given the high prevalence of motor impairments and attention/hyperactivity problems in ASD, for example, either or both might serve as important early targets for intervention, both with respect to reducing non-specific risk and to reducing so-called "comorbidity" in affected children. For example, studies have shown that both exercise and developmental opportunities to improve visuomotor proficiency (through balance exercises and martial arts) may have surprisingly broad positive effects on executive functioning, inattention/hyperactivity and social behavior in young school-aged children ([@R53], [@R54]).

A final critical corollary of causal influence of non-ASD-specific factors is that they will (to the extent that they are operative) seriously confound biomarker studies---including studies of the association between phenotype and i. genotype; ii. brain imaging; and iii. serologic markers---in any study in which they are not uniformly ascertained among both cases and controls. In other words, if control subjects carry quantitative aggregations of the same traits that are contributing to autism susceptibility (in cases), the only signal that can be derived is from the difference. If the difference between most patients with ASD and most controls is that trait liabilities are more diverse (and cumulative) than individually severe, any signal that would be otherwise generated by a contributory trait would be significantly diminished or lost. This has major consequences for study design and raises the possibility that inclusion of non-ASD-specific risk factors in genetic research (again, quantified in both cases and controls) might actually account for elements of "missing heritability" in autism, and may help resolve *apparent* discrepancies between genetic epidemiologic and molecular genetic research in estimating the extent of genetic overlap between autism and other neuropsychiatric impairments (such as ADHD). For example, case-control genetic studies of ASD rarely if ever ascertain or control for sub clinical ADHD traits among the controls, and case control genetic studies of ADHD rarely if ever ascertain or control for sub clinical ASD traits among the controls. This holds true and may confound not only genetic research but all biomarker studies, including investigations in neuroimaging, electrophysiology, and proteomics. Future studies that consider the presence of sub clinical traits of contributing non-specific behavioral impairments in both cases and controls will increase precision in capturing biological signatures that are not necessarily specific to ASD but nevertheless (paradoxically) contributing to its severity.

Specifying measurable autism endophenotypes in infancy {#S6}
======================================================

Sub clinical aggregations of the characterizing traits and features of autism, exhibit a unitary factor structure, whether ascertained among close relatives of individuals with ASD or in the general population, and carry the qualifying features of an endophenotype, one which exhibits robust trait-like stability over the life course from age 3 years through adulthood ([@R55]). The identification of other candidate endophenotypes that are appreciable/measurable in infancy, prior to the timing of the onset of autistic syndromes may prove critical to understanding the early origins of autism and to account for a larger share of the total polygenic risk than may be traceable to behavior variation later in childhood. One of the more promising early predictors of recurrence in autism is the measurement of *social visual attention/engagement* using eye tracking methods, invoked by the observation that one of the most pathognomonic features of the autistic syndrome is abnormality in eye contact. Using methodologies that had identified predictors of autism recurrence in the first year of life ([@R56]), we recently observed that variation in the allocation of attention to social aspects of the visual environment is under stringent genetic control among infants *in the general population*, with effects traceable to the active seeking of social information (44). The indices that were most highly heritable---preferential attention to eye and mouth regions of the face---were those that distinguish typically-developing children from those with autism.

These results implicated deficits in social visual engagement as a neurodevelopmental endophenotype---for both population-wide variation in social-information-seeking and for autism. The replicated observation that most young children who develop autism manifest relative deficiencies in this early developmental competency offers a potential bridge for understanding specific relationships between genes, brain, and behavior in the development of autism. Social visual engagement relates to the construction and maintenance of an ecological niche that mediates social attachment and buffers risk and adversity in early childhood, whether genetic or environmental in origin ([@R44], [@R56]). Johnson and colleagues ([@R57]) hypothesized that key features of autism may be the end result of relative deficiencies in such adaptive mechanisms, rather than a direct consequence of neural pathology. In this view autism is not "inevitable," but a developmental *adaptation* to genetic perturbation, engendered on rare occasions by highly deleterious mutations and perhaps more commonly by permutations and combinations of discrete "sets" of polygenic variation respectively indexed by the behavioral traits described herein. If the particular "adaptation" (or maladaptation when severe) comprised by the autistic syndrome is itself relatively parsimonious, it would reconcile the causal heterogeneity observed in ASD and explain the original observation by Spiker that it is the *syndrome* (not its symptoms) that breeds true, as well as the subsequent observations of a unitary factor structure manifest across the entire range of severity of autistic impairment that occurs in nature.

In any given child, a critical accumulation of developmental disruptions may need to *coaggregate* (additively) to engender the autistic syndrome. In the example of social visual engagement, while nearly all children affected by autism exhibit significant atypicalities, a small proportion of unaffected infants in the general population exhibited the same atypicalities ([@R44]), suggesting that such deficits may be *necessary* but not *sufficient* to cause clinical autistic syndromes, and may be genetically independent from other components of inherited risk. A pilot eye-tracking study of individual children representing a diverse set of loss-of-function mutations in NF1---a recently-recognized quantitative trait locus for autistic impairment ([@R58],[@R59])---made precisely this observation: that decreased attention to faces was associated with elevated autism traits in the affected children, even though many controls had comparably low attention to faces.

Specific polygenic liabilities that are contributory but not independently sufficient to cause ASD would be predicted to be more powerful predictors of autism in multiplex families than in the general population, because of a higher burden of ASD risk within those families in general. Other key candidates for independent endophenotypic contributions to the development of autism (which can be subjected to rigorous analysis across study designs in the manner described here) include more fine-grained contributors to variation in social attention ([@R60],[@R61],[@R62]), nuanced elements of visual search ([@R63]), impairment in the developmental capacity for error-based learning or predictive modeling ([@R64],[@R65]), primary deficits in social motivation ([@R66]); abnormalities in speech perception ([@R67],[@R68]); and deficits in cerebellar learning that might exert joint abnormality in the domains of social and motor functioning ([@R69],[@R70]). A next generation of early developmental studies will need to discern their relative contributions to the development of autism and the extent to which their respective biological origins are independent or shared.

Sex---to date the most robust predictor of all {#S7}
==============================================

Since the male-to-female ASD recurrence ratio stands at 3:1 (manifest from the time of early childhood when autism is first diagnosed), and since the vast majority of all molecular genetic risk tagged to autism lie on autosomes rather than sex chromosomes, sex-specific reduction of the phenotypic expression of genetic susceptibility is believed to occur in the form of a categorical reduction in ASD risk among females, with the absence of a "Carter Effect" ([@R71],[@R72],[@R73]). This suggests that *most* (not all) females are relatively "protected" from *most* (not all)---inherited forms of autism ([@R28],[@R74],[@R75]), and that sex represents a resiliency factor that operates against [numerous]{.ul} (heterogeneous) genetic liabilities to ASD. A recent infant sibling recurrence study ([@R76]) is very notable in this regard: it identified several first year of life predictors of autism (early ASD symptomatology, speed of attentional disengagement, and variation in gaze following), none of which were found to be inherently sexually dimorphic, but all of which more strongly predicted ASD in male than in female siblings of ASD probands, suggesting an interaction between these early life variables and sex in their influence on ASD.

Just as sex may mitigate a diversity genetic susceptibilities to ASD, targeted biological therapies may someday prove capable of reducing impairment across a multitude of causes, as has been the case for ADHD (i.e. treatment with stimulant medication) which is as genetically diverse as autism. The identification of a comprehensive array of contributing elements---both to liability and resilience---can contribute to a reconceptualization of autism as a developmental divergence engendered by a critical accumulation of inherited developmental liabilities, each of which constitutes a potential target for innovative preventive intervention efforts.

Conclusions and implications for future research {#S8}
================================================

The latest generation of developmental studies of autism has built upon the seminal observation of Spiker and colleagues, and revealed that the "unitary" outcome of autism may represent a final common pathway predicted from an array of neurobehavioral susceptibilities that are appreciable before the syndrome is diagnosed, and that each may be engendered by partially-independent sets of genetic variation that do not relate to symptoms in a straightforward way. Given that the *autistic syndrome* (deficits in social communication, restricted interests and repetitive motor behavior) is recognizable across a remarkably wide range of severity from sub clinical to profoundly-impairing ([@R77]), it remains a very high scientific priority to understand how or why the characterizing traits of the condition "travel together" (e.g. shared neural circuitry, or a specifically-recruited adaptation to early developmental stress) and how their severity might be jointly intensified by early co-aggregation with other neuropsychiatric liabilities. Thus, evidence is emerging that autism may be "fractionable" but not *after* it develops, rather *before* it develops. Some of the contributing early developmental liabilities appear not to be specific to ASD---these could account for a significant share of the "missing heritability" of autism, contribute to variable expression of monogenic syndromes, and relate to so-called "co-morbidities"---these are inappropriately named if they actually contribute to the causation of autism itself.

Linking biological processes in the early development of autism ([@R78]) to a set of precursor behavioral traits rather than to a diagnosis of "autism" may advance personalized approaches to developmental intervention, especially if autism represents an epiphenomenon of earlierinteracting susceptibilities. Future research on the neurobiology of autism should focus on understanding why the *co-aggregation* of non-specific liabilities (e.g. inattention and motor coordination)---at levels near the pathologic ends of their respective distributions---might jointly amplify risk for a syndrome of profound *social* disability, with timing of onset in the second year of life.

The path forward for early behavioral phenotyping will benefit from the identification of highly heritable intermediate phenotypes that may more directly link inherited risk to brain and behavioral development than is possible by molecular genetic associations to symptomatology *after* autism develops. To elucidate an early endophenotypic structure for the development of autism will require testing of a next generation of viable early phenotypic candidates (both behavioral and neural-circuitry-based) in a manner that is epidemiologically rigorous, in which the distinction between (a) prediction of ASD in the general population and (b) prediction of ASD recurrence in families affected by ASD, is closely attended to. Particularly important are studies of the normative *relationships* between early endophenotypic candidates, to determine the extent to which such candidates are genetically independent, the extent to which they influence one another over the course of early development (even if they begin independently), and the extent to which they individually and/or jointly predict autism. Such studies will help generate norms for the relationships between key quantitative "axes" of early development--- including sensorimotor function, general cognition, language, and the respective developmental capacities for reciprocial social behavior, attention, and emotion regulation---that may someday function in the same way that height-versus-weight charts inform pediatric practice, i.e. by the interpretation of a given variable score (eg. weight) not in absolute terms but in relation to other core factors that influence it (eg. height). For example, in monitoring the developmental progress of an infant, it would be extremely helpful to know just how much erosion in the capacity for emotion regulation to *expect* from a one standard deviation reduction in the capacity for reciprocal social behavior, and whether that relationship is linear or curvilinear. No such relational norms exist for early behavioral development.

In addition, studies of the influence (and amelioration) of any given behavioral liability on the development of ASD should be conducted whenever possible within study designs that incorporate control for any/all specifiable inherited risk for ASD, including genotype whenever possible, family genetic background liability for ASD (including affectation status of first degree relatives and endophenotypic characterization of parents), and phenotyping of subjects for a comprehensive array of known behavioral liabilities related to ASD (i.e. attention and motor coordination). Genetic and neurobiologic studies to discover new biomarkers must recognize that sub clinical variations of endophenotypic contributors to autism abound in "control" subjects, and will confound such studies if left unmeasured among the unaffected individuals in case-control research designs. Finally, it is possible that the discovery of polygenic risk signals for autism may be substantially refined if a) linked to endophenotypes rather than the diagnosis of autism and b) derived from populations representing the entire range of quantitative variation in the respective phenotype, and including measurement of all endophenotypic contributors to autism within both affected and unaffected subjects.
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![Mechanisms by which genetic influences that are non-specific to autism may compound autistic severity and incur "comorbid" affectation with non-ASD-specific traits (ADHD as an example here). 1. Specific influences on ASD 2. Amplification of ASD severity by a non-ASDspecific causal influence. ADHD attention-deficit/hyperactivity disorder, ASD autism spectrum disorder. Note that in this model, inherited liabilities that are initially independent become correlated (a) by definition when contributing to the development of autism, and (b) by reciprocal interaction over the course of later development, after the respective syndromes of disability are manifest.](nihms-1509808-f0001){#F1}
